Oxidant status and lipid composition of erythrocyte membranes in patients with type 2 diabetes, chronic liver damage, and a combination of both pathologies

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Hernández Muñoz, Rolando ^a   Olguín Martínez, Marisela ^a   Aguilar Delfín, Irma ^b   Sánchez Sevilla, Lourdes ^a   García García, Norberto ^a   Díaz Muñoz, Mauricio ^a,c  

^a INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

^b INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

^c INSTITUTO DE NEUROBIOLOGÍA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED DIENES; DIABETIC PATIENT; ERYTHROCYTE MEMBRANE; HEALTHY INDIVIDUALS; LIPID COMPOSITION; LIVER CIRRHOSIS; MEMBRANE COMPOSITION; PATHOLOGICAL CONDITIONS;

AMINO ACIDS; CELL MEMBRANES; PATHOLOGY; PHOSPHOLIPIDS;

BLOOD;

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKADIENE; BILIRUBIN; BLOOD CLOTTING FACTOR; C REACTIVE PROTEIN; CARBONYL DERIVATIVE; CHOLESTEROL; CYSTEINE; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN A1C; NITRITE; PHOSPHOLIPID; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; LIPID; NITRIC OXIDE; OXIDIZING AGENT;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE ASSOCIATION; ENZYME ACTIVITY; ERYTHROCYTE MEMBRANE; HUMAN; HUMAN CELL; INSULIN RESISTANCE; LIPID COMPOSITION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; POPULATION; BLOOD; CASE CONTROL STUDY; LIVER DISEASE; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY;

CASE-CONTROL STUDIES; CHOLESTEROL; CYSTEINE; DIABETES MELLITUS, TYPE 2; ERYTHROCYTE MEMBRANE; HUMANS; LIPIDS; LIVER CIRRHOSIS; LIVER DISEASES; NITRIC OXIDE; NITRITES; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PHOSPHOLIPIDS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84879344486     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/657387     Document Type: Article

References (53)

1. Zimmet P., Alberti K., Shaw J., Global and societal implications of the diabetes epidemic. Nature 2001 414 6865 782 787 2-s2.0-0035856920 10.1038/414782a
2. Baynes J. W., Role of oxidative stress in development of complications in diabetes. Diabetes 1991 40 4 405 412 2-s2.0-0025732948
3. Hoeldtke R. D., Bryner K. D., McNeill D. R., Warehime S. S., van Dyke K., Hobbs G., Oxidative stress and insulin requirements in patients with recent-onset type I diabetes. Journal of Clinical Endocrinology and Metabolism 2003 88 4 1624 1628 2-s2.0-0038697977 10.1210/jc.2002-021525
4. Taysi S., Polat F., Gul M., Sari R., Bakan E., Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatology International 2002 21 5 200 204 2-s2.0-0036192815 10.1007/s00296-001-0163-x
5. Wu G., Meininger C. J., Arginine nutrition and cardiovascular function. Journal of Nutrition 2000 130 11 2626 2629 2-s2.0-0033744268
6. Hunt J. V., Smith C. C. T., Wolff S. P., Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 1990 39 11 1420 1424 2-s2.0-0025096104
7. Fitzgibbons J. F., Koler R. D., Jones R. T., Red cell age related changes of hemoglobins A I a + b and A I c in normal and diabetic subjects. Journal of Clinical Investigation 1976 58 4 820 824 2-s2.0-0017193387
8. Abuja P. M., Albertini R., Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins. Clinica Chimica Acta 2001 306 1-2 1 17 2-s2.0-0035078318 10.1016/S0009-8981(01)00393-X
9. Paroni R., Ceriotti F., Galanello R., Battista Leoni G., Panico A., Scurati E., Paleari R., Chemello L., Quaino V., Scaldaferri L., Lapolla A., Mosca A., Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma. Clinical Biochemistry 2007 40 18 1398 1405 2-s2.0-36348954532 10.1016/j.clinbiochem.2007.08.001
10. Faure P., Corticelli P., Richard M. J., Arnaud J., Coudray C., Halimi S., Favier A., Roussel A. M., Lipid peroxidation and trace element status in diabetic ketotic patients: influence of insulin therapy. Clinical Chemistry 1993 39 5 789 793 2-s2.0-0027229692
11. Velazquez E., Winocour P. H., Kesteven P., Alberti K. G. M. M., Laker M. F., Relation of lipid peroxides to macrovascular disease in type 2 diabetes. Diabetic Medicine 1991 8 8 752 758 2-s2.0-0025866522
12. Meltzer A. A., Everhart J. E., Association between diabetes and elevated serum alanine aminotransferase activity among Mexican Americans. American Journal of Epidemiology 1997 146 7 565 571 2-s2.0-0031471332
13. Everhart J. E., Digestive diseases and diabetes. Diabetes in America 1995 2nd Washington, DC, USA National Institutes of Health. National Institute of Diabetes and Digestive and Kidney Diseases, GPO 631 659
14. Miyake Y., Eguchi H., Shinchi K., Oda T., Sasazuki S., Kono S., Glucose intolerance and serum aminotransferase activities in Japanese men. Journal of Hepatology 2003 38 1 18 23 2-s2.0-0037230441 10.1016/S0168-8278(02)00323-9
15. Perry I. J., Wannamethee S. G., Shaper A. G., Prospective study of serum γ -glutamyltransferase and risk of NIDDM. Diabetes Care 1998 21 5 732 737 2-s2.0-0031766447 10.2337/diacare.21.5.732
16. Fagiuoli S. R., van Thiel D. H., Rustgi V. K., van Thiel D. H., The liver in endocrine disorders. The Liver in Systemic Disease 1993 New York, NY, USA Raven Press 285 301
17. Targher G., Byrne C. D., Diagnosis and management of nonalcoholic fatty liver disease and its hemostatic/thrombotic and vascular complications. Seminars in Thrombosis and Hemostasis 2013 39 2 214 228 10.1055/s-0033-1334866
18. Costantini S., Capone F., Guerriero E., Cytokinome profile of patients with type 2 diabetes and/or chronic hepatitis C infection. PLoS One 2012 7 6 10.1371/journal.pone.0039486 e39486
19. Cimino L., Oriani G., D'Arienzo A., Manguso F., Loguercio C., Ascione A., Caporaso N., Del Vecchio Blanco C., Budillon G., Interactions between metabolic disorders [diabetes, gallstones, and dyslipidaemia] and the progression of chronic hepatitis C virus infection to cirrhosis and hepatocellular carcinoma. A cross-sectional multicentre survey. Digestive and Liver Disease 2001 33 3 240 246 2-s2.0-0035003871
20. Youssef W., McCullough A. J., Diabetes mellitus, obesity, and hepatic steatosis. Seminars in Gastrointestinal Disease 2002 13 1 17 30 2-s2.0-0036208020
21. Hernández-Muñoz R., Glender W., Díaz-Muñoz M., García-Sáinz J. A., Chagoya de Sánchez V., Effects of adenosine on liver cell damage induced by carbon tetrachloride. Biochemical Pharmacology 1984 33 16 2599 2604
22. Gaitonde M. K., A spectrophotometric method for the direct determination of cysteine in the presence of other naturally occurring amino acids. Biochemical Journal 1967 104 2 627 633 2-s2.0-0014118789
23. 15N]nitrate in biological fluids. Analytical Biochemistry 1982 126 1 131 138 2-s2.0-0020448709
24. Aguilar-Delfín I., López-Barrera F., Hernández- Muñoz R., Selective enhancement of lipid peroxidation in plasma membrane in two experimental models of liver regeneration: partial hepatectomy and acute CCl4 administration. Hepatology 1996 24 3 657 662 2-s2.0-0029819768 10.1053/jhep.1996.v24.pm0008781339
25. Levine R. L., Garland D., Oliver C. N., Amici A., Climent I., Lenz A.-G., Ahn B.-W., Shaltiel S., Stadtman E. R., Determination of carbonyl content in oxidatively modified proteins. Methods in Enzymology 1990 186 464 478 2-s2.0-0025102226 10.1016/0076-6879(90)86141-H
26. Hernández-Muñoz R., Baraona E., Blacksberg I., Lieber C. S., Characterization of the increased binding of acetaldehyde to red blood cells in alcoholics. Alcoholism: Clinical and Experimental Research 1989 13 5 654 659 2-s2.0-0024424849
27. Chiang D. J., Pritchard M. T., Nagy L. E., Obesity, diabetes mellitus, and liver fibrosis. American Journal of Physiology 2011 300 5 G697 G702 2-s2.0-79955551252 10.1152/ajpgi.00426.2010
28. Malaguarnera M., di Rosa M., Nicoletti F., Malaguarnera L., Molecular mechanisms involved in NAFLD progression. Journal of Molecular Medicine 2009 87 7 679 695 2-s2.0-67649448956 10.1007/s00109-009-0464-1
29. Jou J., Choi S. S., Diehl A. M., Mechanisms of disease progression in nonalcoholic fatty liver disease. Seminars in Liver Disease 2008 28 4 370 379 2-s2.0-56649083495 10.1055/s-0028-1091981
30. Birben E., Sahiner U. M., Sackesen C., Erzurum S., Kalayci O., Oxidative stress and antioxidant defense. World Allergy Organization Journal 2012 5 1 9 19 2-s2.0-84857274709 10.1097/WOX.0b013e3182439613
31. Booth G. L., Kapral M. K., Fung K., Tu J. V., Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. The Lancet 2006 368 9529 29 36 2-s2.0-33745400514 10.1016/S0140-6736(06)68967-8
32. Siu G. M., Draper H. H., Metabolism of malonaldehyde in vivo and in vitro. Lipids 1982 17 5 349 355 2-s2.0-0019920815
33. Girotti A. W., Mechanisms of lipid peroxidation. Journal of Free Radicals in Biology and Medicine 1985 1 2 87 95 2-s2.0-0022336547
34. Kelly F. J., Mudway I. S., Protein oxidation at the air-lung interface. Amino Acids 2003 25 3-4 375 396 2-s2.0-0346731071 10.1007/s00726-003-0024-x
35. Lyons J., Rauh-Pfeiffer A., Yu Y. M., Lu X.-M., Zurakowski D., Tompkins R. G., Ajami A. M., Young V. R., Castillo L., Blood glutathione synthesis rates in healthy adults receiving a sulfur amino acid-free diet. Proceedings of the National Academy of Sciences of the United States of America 2000 97 10 5071 5076 2-s2.0-0034625140 10.1073/pnas.090083297
36. Lu S. C., Regulation of glutathione synthesis. Current Topics in Cellular Regulation 2001 36 95 116 2-s2.0-0033655446 10.1016/S0070-2137(01)80004-2
37. Townsend D. M., Tew K. D., Tapiero H., The importance of glutathione in human disease. Biomedicine and Pharmacotherapy 2003 57 3 145 155 2-s2.0-0037733975 10.1016/S0753-3322(03)00043-X
38. Loguercio C., del Vecchio Blanco C., Coltorti M., Nardi G., Alteration of erythrocyte glutathione, cysteine and glutathione synthetase in alcoholic and non-alcoholic cirrhosis. Scandinavian Journal of Clinical and Laboratory Investigation 1992 52 3 207 213 2-s2.0-0026719844
39. Srinivasan S., Hatley M. E., Bolick D. T., Palmer L. A., Edelstein D., Brownlee M., Hedrick C. C., Hyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells. Diabetologia 2004 47 10 1727 1734 2-s2.0-11144262141 10.1007/s00125-004-1525-1
40. Shah V., Toruner M., Haddad F., Cadelina G., Papapetropoulos A., Choo K., Sessa W. C., Groszmann R. J., Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat. Gastroenterology 1999 117 5 1222 1228 2-s2.0-0032738990 10.1016/S0016-5085(99)70408-7
41. Shah V., Cao S., Hendrickson H., Yao J., Katusic Z. S., Regulation of hepatic eNOS by caveolin and calmodulin after bile duct ligation in rats. American Journal of Physiology 2001 280 6 G1209 G1216 2-s2.0-0034973581
42. Baranska J., Mechanism of the ATP-dependent phosphatidylserine synthesis in liver subcellular fractions. FEBS Letters 1989 256 1-2 33 37 2-s2.0-0024419043 10.1016/0014-5793(89)81712-0
43. Voelker D. R., Phosphatidylserine translocation to the mitochondrion is an ATP-dependent process in permeabilized animal cells. Proceedings of the National Academy of Sciences of the United States of America 1989 86 24 9921 9925 2-s2.0-0024847351 10.1073/pnas.86.24.9921
44. Shinitzky M., Inbar M., Difference in microviscosity induced by different cholesterol levels in the surface membrane lipid layer of normal lymphocytes and malignant lymphoma cells. Journal of Molecular Biology 1974 85 4 603 615 2-s2.0-0016384733
45. van Blitterswijk W. J., van Hoeven R. P., van der Meer B. W., Lipid structural order parameters (reciprocal of fluidity) in biomembranes derived from steady-state fluorescence polarization measurements. Biochimica et Biophysica Acta 1981 644 2 323 332 2-s2.0-0019886355
46. Williams K. H., Shackel N. A., Gorrell M. D., McLennan S. V., Twigg S. M., Diabetes and nonalcoholic fatty liver disease: a pathogenic duo. Endocrine Reviews 2013 34 1 84 129 10.1210/er.2012-1009
47. Davis T. M., Peters K. E., Bruce D. G., Davis W. A., Prevalence, incidence, and prognosis of hepatobiliary disease in community-based patients with type 2 diabetes: the Fremantle Diabetes Study. The Journal of Clinical Endocrinology & Metabolism 2012 97 1581 1588
48. Hickman I. J., Macdonald G. A., Impact of diabetes on the severity of liver disease. American Journal of Medicine 2007 120 10 829 834 2-s2.0-34548860072 10.1016/j.amjmed.2007.03.025
49. Knobler H., Schattner A., TNF-chronic hepatitis C and diabetes: a novel triad. QJM 2005 98 1 1 6 2-s2.0-12444303314 10.1093/qjmed/hci001
50. Kuriyama S., Miwa Y., Fukushima H., Nakamura H., Toda K., Shiraki M., Nagaki M., Yamamoto M., Tomita E., Moriwaki H., Prevalence of diabetes and incidence of angiopathy in patients with chronic viral liver disease. Journal of Clinical Biochemistry and Nutrition 2007 40 2 116 122 2-s2.0-34247267025 10.3164/jcbn.40.116
51. Jáquez-Quintana J. O., García-Compean D., González-González J. A., The impact of diabetes mellitus in mortality of patients with compensated liver cirrhosis-a prospective study. Annals of Hepatology 2011 10 1 56 62
52. Fujiwara F., Ishii M., Taneichi H., Miura M., Toshihiro M., Takebe N., Ishida W., Kaneko Y., Kato A., Suzuki K., Satoh J., Low incidence of vascular complications in patients with diabetes mellitus associated with liver cirrhosis as compared with type 2 diabetes mellitus. Tohoku Journal of Experimental Medicine 2005 205 4 327 334 2-s2.0-20244369731 10.1620/tjem.205.327
53. Loria P., Lonardo A., Anania F., Liver and diabetes. A vicious circle. Hepatology Research 2013 43 51 64